CN101869224A - Feed additive for improving lactation performance of lactating sows and preparation method thereof - Google Patents
Feed additive for improving lactation performance of lactating sows and preparation method thereof Download PDFInfo
- Publication number
- CN101869224A CN101869224A CN 201010200952 CN201010200952A CN101869224A CN 101869224 A CN101869224 A CN 101869224A CN 201010200952 CN201010200952 CN 201010200952 CN 201010200952 A CN201010200952 A CN 201010200952A CN 101869224 A CN101869224 A CN 101869224A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- feed addictive
- sow
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006651 lactation Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000003674 animal food additive Substances 0.000 title abstract description 9
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 20
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 20
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 16
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 13
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000010457 zeolite Substances 0.000 claims abstract description 13
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 19
- 240000008027 Akebia quinata Species 0.000 claims description 15
- 235000007756 Akebia quinata Nutrition 0.000 claims description 15
- 239000003595 mist Substances 0.000 claims description 14
- 241000245665 Taraxacum Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000722953 Akebia Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132003 Atractylis Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 54
- 230000001976 improved effect Effects 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 26
- 239000003814 drug Substances 0.000 description 18
- 235000013336 milk Nutrition 0.000 description 18
- 239000008267 milk Substances 0.000 description 18
- 210000004080 milk Anatomy 0.000 description 18
- 210000000481 breast Anatomy 0.000 description 11
- 230000004083 survival effect Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000012173 estrus Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000000857 drug effect Effects 0.000 description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 235000014590 basal diet Nutrition 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000762 glandular Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000021239 milk protein Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- XNOPRXBHLZRZKH-MQYCRUOZSA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1C(CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-MQYCRUOZSA-N 0.000 description 2
- 229940082408 oxytocin injection Drugs 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940124301 concurrent medication Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000023247 mammary gland development Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a feed additive for improving the lactation performance of lactating sows and a preparation method thereof. The feed additive consists of the following components in part by weight: 0 to 60 parts of cowherb seed, 5 to 8 parts of dandelion, 8 to 10 parts of atractylis, 5 to 8 parts of akebia stem, 5 parts of astragalus, 5 pars of liquoric root, and the balance of zeolite powder. The feed additive for improving the lactation performance of the lactating sows has the advantages of obvious improvement on the lactation performance of the lactating sows (lactation yield and lactic quality), low addition volume, good effect, no residue, and no toxic or side effects.
Description
Technical field
The present invention relates to a kind of feed addictive, particularly relate to a kind of feed addictive of the raising lactation performance of lactating sows based on the seed of cowherb.
Background technology
Breast milk is that piglet is nascent to the source of the main nutrient matter between weaning period, and the quality and quantity of breast milk has determined the survival rate and the speed of growth of piglet.The low milking capacity of sow can directly cause piglet nutritional deficiency, slow, the death rate of growth to increase, and influence the weaned piglet body weight, and the aggravation stress of baby pigs caused ablaction also influences the subsequent growth growth.Therefore, the elementary object between sows in lactation is to guarantee the enough nutrition of sow absorption, and the milk that secretion is sufficient keeps suitable body condition, and sow can normally be oestrused behind weaned piglet and ovulation, enters the next one breeding cycle.Have data to show, compare with foreign outstanding sow milk performance, the lactation potentiality of domestic most milking sows are only brought into play about seventy percent, thereby room for promotion is very big.Domestic many scholars have done a large amount of research to this, as increasing the addition of energy, proteins,vitamins,and minerals in agent of feed for nursing sow, but produce little effect.That have even in sow feed, add the feed addictives of a large amount of antibiotic and so on, not only can not improve the milk performance of sow, but also animal is developed immunity to drugs, have a strong impact on reproductive performance of sow and the health of piglet.For this reason, people urgently wish to develop a kind of milk performance that had both improved milking sow, noresidue again, the feed addictive that has no side effect.
Chinese herbal medicine is the rarity of motherland's medical science, and China people have the history of long use Chinese herbal medicine.Chinese herb feed additive has functions such as promoting growth, prevent disease, raising lactation, use the back to the animals and animal product noresidue, have no side effect, be difficult for developing immunity to drugs.Because the use of Chinese herbal medicine also rests on the basis of experience and conventional formulation, add that traditional research method and manufacture craft fall behind, the Chinese herbal medicine of feasible China is not well utilized and is developed, especially in feed additive industry, the utilization of Chinese herbal medicine is very not extensive, and effect also is under suspicion.Mainly there is following several big problem in restriction Chinese herbal feed additive large-scale application: (1) adding proportion height: because conventional method adopts common pulverizing, drug effect in the plant can not be utilized by the animal fast Absorption, therefore everybody adopts high addition more, generally need add 0.5%～5% to does not wait, cause cost to raise, and high addition causes the feed palatability poor, and animal produces few food or food refusal behavior; (2) drug effect is slow and waste is serious: Chinese medicine plays a role by group effect, does not reach the Western medicine level on taking stopgap measures fully, because plant directly enters in the intestines and stomach, the active ingredient in the plant could finally be absorbed by animal after by plant cell wall.Because food has only certain stop effect in intestines and stomach, some active ingredient fails in time to be absorbed by animal, just along with chyme excretes, makes drug effect can not get embodying; (3) process technology is improper: the someone proposes to adopt advanced microwave leaching technology, Chinese herbal medicine effective ingredients is improved significantly, but different pharmaceutical leach extraction method difference, the solvent difference, technical difficulty is very big, the cost of investment height, and have pollution problems, the extract unit cost that its production obtains is extremely high, has limited popularization.
We are verified in research several years ago, adopt suitable cell grade micro mist broken, and effect is poor unlike extracting effect, not only reduce addition but also reduce cost, suitable applying.
Broken being meant with the biological cell broken wall of cell grade micro mist is the comminution process of purpose, and it is not purpose with the smashing fineness, but pursues the sporoderm-broken rate of cell.Broken by the cell grade micro mist, the medium particle diameter of former green material can be brought up to more than 300 orders from 40～80 orders of traditional handicraft, for general medicinal material, the breaking-wall cell rate under this fineness condition is greater than 95%.Cell intracellular active ingredient behind broken wall fully comes out, the rate of release and the burst size of medicine can significantly improve.The medicinal material particle is after the cell grade micro mist is broken, and microscopically is observed only has the minute quantity intact cell to exist.The cell grade micro mist is broken to mainly contain following advantage aborning: (1) increases the drug absorption rate, improves the Chinese traditional medicine biology utilization rate.The main pharmacodynamics composition of Chinese medicine is distributed in the cell and cytoplasm usually, and based in the cell.Active ingredient comes out in its cell behind the breaking-wall cell, and drug effect increases substantially, and onset speed is fast; (2) help the retains biological activity composition, improve drug effect.In the broken process of cell grade micro mist, can not produce superheating phenomenon through control, or under low-temperature condition, carry out, and pulverizing speed is fast, helps keeping the bioactive ingredients and the various nutritional labeling of non-refractory, thereby improve drug effect; (3) conservation is convenient to use.Chinese medicine is after the cell grade micro mist is broken, and available smaller dose obtains the curative effect of former prescription (decoction).General medicine, after the cell grade micro mist is broken, no longer pass through lixiviate, etc. processing, reduced loss of active ingredients in the production link, maximally utilised raw material, and, be convenient to take because the increase of fineness can improve mouthfeel.On the other hand, be in totally-enclosed dustless system, to carry out because of the cell grade micro mist is broken, can effectively avoid outside contamination, the content of microorganisms of product and dust are controlled.Predictably, the broken technology of Chinese medicine cell grade micro mist will provide preferable approach for the Chinese medicine utilization.
From the modern nutriology theory analysis, the contained alkaloid of Chinese herbal feed additive, polysaccharide, glucoside, volatile fatty acid, organic acid etc. all are bioactivators, to improving mammiferous milk performance good action are arranged.Some composition in the Chinese herb feed additive and mammogenesis, galactin synthetic and secrete closely related, as promote prolactin, cortex hormone of aadrenaline secretion etc., the Chinese herbal medicine that quickens galactosis is by improving body courier's material (cAMP and cGMP) level, regulate the metabolic activity of mammary glandular cell, promote the growth of the synthetic and mammary gland of mammary gland anabolism, milk composition, realize increasing the effect of breast.The seed of cowherb has activating blood to promote menstruation, the effect of lactogenesis detumescence, can treat agalactia, through close, disease such as dysmenorrhoea, acute mastitis swell and ache.The cell culture experiments confirmation, the seed of cowherb, the Radix Astragali can promote mammary glandular cell to absorb the outer free amino acid of born of the same parents, make the synthetic increase of mammary glandular cell albumen by reinventing mammary glandular cell inside is Ultrastructural.Current awareness search work station (Z09) looks into new confirmation through the Ministry of Education, is that the feed addictive of the raising lactation performance of lactating sows of master side does not appear in the newspapers with the seed of cowherb.
Summary of the invention
Technical problem to be solved by this invention is: overcome the deficiencies in the prior art, a kind of feed addictive of improving lactation performance of lactating sows and preparation method thereof that is used to is provided.
The present invention solves the technical scheme that its technical problem takes: this feed addictive that is used to improve lactation performance of lactating sows is composed of the following components, and the total weight parts of described each component is 100 parts, wherein,
50～60 parts of the seeds of cowherb
5～8 parts of dandelions
8～10 parts of rhizoma atractylodis
5～8 parts of akebis
5 parts of the Radixs Astragali
5 parts in Radix Glycyrrhizae
All the other are zeolite powder.
Further, by weight, rhizoma atractylodis of the present invention are that 8 parts, akebi are 5 parts.
Further, by weight, the seed of cowherb of the present invention is that 50 parts, dandelion are 5 parts.
The preparation method that the present invention is used to improve the feed addictive of lactation performance of lactating sows is: with weight portion is that 50～60 parts the seed of cowherb, 5～8 parts dandelion, 8～10 parts rhizoma atractylodis, 5～8 parts akebi, 5 parts the Radix Astragali and 5 parts Radix Glycyrrhizae mix, after the cell grade micro mist is broken to particle diameter is 25～40 microns, add zeolite powder again and mix, the total amount of the described seed of cowherb, dandelion, rhizoma atractylodis, akebi, the Radix Astragali, Radix Glycyrrhizae and zeolite powder is 100 parts.
Further, the weight portion of rhizoma atractylodis of the present invention is 8 parts, and the weight portion of akebi is 5 parts.
Further, the weight portion of the seed of cowherb of the present invention is 50 parts, and the weight portion of dandelion is 5 parts.
Positive beneficial effect of the present invention is:
(1) can obviously improve the milk performance (lactation amount and breast quality) of milking sow.Chinese veterinarian's theory thinks that milk is given birth to by sanguification, and laboured breathing is the deficiency of blood then, and the deficiency of blood then breast is few, and the sow between lactation often shows the laboured breathing deficiency of blood, weak few breast, qi depression to blood stasis because of being subjected to influence of various factors such as physiology, pathology, weather, feeding and management.Feed addictive of the present invention system select for use natural authentic medicinal herbs by a certain percentage compatibility form, can obviously improve the lactation amount of milking sow; And owing to do not contain artificial synthetic chemicals, particularly do not contain antibiotic medicine, the Ruzhong does not have the synthetic material residual, has improved newborn quality.
In component of the present invention:
The seed of cowherb: property hardship, flat, return liver, stomach warp, have the disappear effect of carbuncle of activating blood to promote menstruation, lactogenesis, can treat diseases such as alactation, acute mastitis, carbuncle be swollen;
Dandelion: property hardship, cold, return liver, the stomach warp has effect clearing heat and detoxicating, the carbuncle that disappears dissipating bind, cures mainly the inside and outside all cards of hot carbuncle carbuncle, holds concurrently and can dredge strongly fragrant logical breast, is the key medicine of treatment acute mastitis;
Rhizoma atractylodis: property suffering, hardship, temperature, return spleen, stomach, Liver Channel, the effect that have drying damp and strengthening spleen, expelling wind and clearing away cold, makes eye bright is used for the treatment of abdominal fullness and distention, disease such as the oedema of having loose bowels, beriberi Wei lame, arthralgia due to wind-dampness;
Akebi: property hardship, cold, the thoughts of returning home, small intestine, urinary bladder channel have purging intense heat row water, promoting blood circulation effect, cure mainly hot urination, stranguria with turbid discharge, oedema, and be irritable feverish sensation in chest, larynx numbness pharyngalgia, inflexible pain all over, the women through close, alactation;
The Radix Astragali: property is sweet, warm, returns lung, the spleen channel, has the effect of benefiting qi and raising yang, strengthening exterior and reducing sweat, inducing diuresis for removing edema, detoxification myogenic, can treat the disease of all Qi and blood deficiencies, as diseases such as splenasthenic diarrhea, cough due to deficiency of the lung, metroptosis, spontaneous perspiration, night sweat, oedema;
Radix Glycyrrhizae: property is sweet, flat, returns spleen, stomach, the heart, lung channel, has the effect with middle emergency, moistening lung, detoxifcation, coordinating the drug actions of a prescription, can treat weakness of the spleen and the stomach, burnout food less, diseases such as the painful palpitaition of abdomen, carbuncle pyogenic infections from tumour or sore, abscess of throat.More than all medicine coordination linkages, can make in the body qi and blood full, strengthen physiological function, improve lactation amount.
(2) feed addictive of the present invention, required addition few (in feed, generally adding), effective according to 0.08～0.12% ratio.And have adding proportion height (general add percentage by weight be more than 0.5%), cost height in the traditional Chinese medicine interpolation process, problems such as drug effect is slow, waste is serious and process technology is improper; And the present invention adopts the broken technology of cell grade micro mist that effective ingredient is directly come out, and has improved the absorption and the bioavilability of medicine greatly, shortens the drug effect time, not only reduces addition but also reduce cost definite effect simultaneously.
(3) feed addictive of the present invention, has no side effect at noresidue.The antibiotic that mostly contains chemical synthesis in the conventional feed, even hormone etc., thereby these compositions very easily cause the secondary residual human health that jeopardizes of poison, have also polluted ecological environment.And feed addictive of the present invention all adopts non-harmful natural Chinese medicinal herb, does not add any chemical synthesis antiseptic and poisonous and harmful substance, does not produce the cross-resistance of people and animals' concomitant medication, has thoroughly avoided the secondary residual drawback of conventional feed poisoning.
The specific embodiment
In following examples, feed addictive herbal raw material of the present invention is purchased the letter Li De pharmaceutcal corporation, Ltd in Haozhou, Anhui Province city.
Embodiment 1
Respectively with the seed of cowherb, dandelion, rhizoma atractylodis, akebi, the Radix Astragali, the Radix Glycyrrhizae oven dry, the weighing seed of cowherb 500 restrains respectively then, dandelion 50 grams, rhizoma atractylodis 80 grams, akebi 50 grams, the Radix Astragali 50, Radix Glycyrrhizae 50 grams, section arrangement then, mix, mixed mixture is at first carried out 60 order coarse crushings, it is broken to adopt QYF type fluidized bed air flow crusher to carry out the cell grade micro mist then, it is 25～40 microns (approximately fineness is 350～500 orders) that mixture is crushed to average grain diameter, add carrier zeolite powder 220 grams (fineness is 100 orders) again, total amount reaches 1000 grams, mix once more, promptly obtain feed addictive of the present invention.
Embodiment 2
The raw material and the weight thereof that add in the present embodiment are respectively: the seed of cowherb 600 grams, dandelion 80 grams, rhizoma atractylodis 100 grams, akebi 80 grams, the Radix Astragali 50, Radix Glycyrrhizae 50 grams, carrier zeolite powder 40 grams (100 order fineness), make total amount reach 1000 grams, prepare feed addictive of the present invention according to the preparation method identical with embodiment 1.
Embodiment 3
The raw material and the weight thereof that add in the present embodiment are respectively: the seed of cowherb 550 grams, dandelion 70 grams, rhizoma atractylodis 90 grams, akebi 70 grams, the Radix Astragali 50, Radix Glycyrrhizae 50 grams and carrier zeolite powder 120 grams (100 order fineness), make total amount reach 1000 grams, prepare feed addictive of the present invention according to the preparation method identical with embodiment 1.
Application examples 1
Test period: test was since on August 10th, 2005, October 31 in 2005 end of day, 82 days test periods (since pig farm scale sow 500 surplus, the test pig sample size is many, so can not once obtain testing parturient sow required the time, therefore we select term in the stage close sow as sample, and 52 days of more single sow experimental period 82 days test periods are long).
Test site: Xu Shan plant of Jiaxing City food meat Co., Ltd.
The selection of test pig and grouping: select 36 of the good multiparity sow accumulative totals of just before giving birth length close, conditional likelihood in term, be divided into 2 processed group at random according to the roughly close principle of health status, parity and the body weight of sow, be control group and test group, each processed group is established 3 repetitions, and each repeats 6.Brought into use in antenatal 7 days, and 52 days experimental periods, wherein 35 days lactations, observed sow and wean to the inter oestrual period first time (10 day observation period).
Basal diet prescription and nutrient content: as shown in table 1.
The test daily ration: the feed addictive that embodiment 1 is prepared is that 0.1% consumption substitutes 0.1% zeolite powder in the basal ration prescription as the test daily ration according to percentage by weight.
Table 1 basal diet prescription and nutrient composition content
| Raw material | Prescription (percentage by weight, %) | Main nutritive index | Level |
| Corn | ??58 | ??DE(MJ/kg) | ??13.2 |
| Dregs of beans | ??22 | CP (percentage by weight, %) | ??17.2 |
| Imported fish meal | ??2 | CF (percentage by weight, %) | ??3.5 |
| Soya-bean oil | ??0.5 | EE (percentage by weight, %) | ??3.3 |
| Wheat bran | ??12.8 | Ash content (percentage by weight, %) | ??5.8 |
| Raw material | Prescription (percentage by weight, %) | Main nutritive index | Level |
| Calcium monohydrogen phosphate | ??1.2 | Lys (percentage by weight, %) | ??0.85 |
| Stone flour | ??1.2 | Met+Cys (percentage by weight, %) | ??0.55 |
| Salt | ??0.3 | Thr (percentage by weight, %) | ??0.7 |
| Zeolite powder | ??1 | Ca (percentage by weight, %) | ??0.88 |
| Compound premix | ??1 | Total P (percentage by weight, %) | ??0.61 |
Annotate: contain in every kilogram of feed: the rope A 8000IU that supports one's family, vitamin D 1000IU; Below be milligram: vitamin E 35, vitamin K
32, Cobastab
12, Cobastab
26, Cobastab
120.025, biotin 0.2, folic acid 2, pantothenic acid 25, nicotinic acid 50; Cu 5, and Zn 75, and Fe 80, and Mn 10, and Se 0.25, I0.3, choline 500,15% aureomycin 300.Wherein DE, Lys, Met+Cys and Thr are calculated value, and all the other are measured value.
Feeding and management: pig house carries out disinfection before the test, promptly just enters after the test pig grouping and tries the phase.The sow of control group is used basal diet feeding, the sow service test daily ration feeding of test group.Management method is carried out according to the pig farm conventional program.For disease occurring, carry out record and treatment in time.Piglet when birth nest is weighed (removing weak young) and is carried out record, and piglet 35 ages in days (during off-test) 9:00 in the morning weighs and record on an empty stomach.Write down survive number and pig mental status only etc.
Detect index: (1) performance test: weigh for unit record nest young number alive, initial weight, wean (wean of 35 ages in days) end with the nest, and calculate average daily gain, nascent individual weight, 35 age in days individual weights, add up above data, and record oestrus of sow interval (10 days observation periods); (2) collection and the analysis of milk sample: adopt preceding 45 minutes of breast piglet and sow isolated, in lactation the 21st day respectively in the past, in, the nipple at back three positions gathers newborn sample with adopting newborn device, merging.From sow auricular vein oxytocin injection 30 units, every sow was adopted 20mL before the breast sample was gathered, and the milk sample places-20 ℃ of freezing preservations.Adopt the content of infrared ray milk composition analysis-e/or determining butterfat, lactoprotein, lactose.
Data are handled: adopt SPSS (16.0) that data are handled, and carry out one-way analysis of variance and least significant difference method (LSD) check.Data are with average ± standard deviation (X ± SD) expression.
Test result:
(1) interpolation feed addictive of the present invention is as shown in table 2 to the result of weaned piglet litter weight influence:
Table 2
| Group | The nest number | Birth litter weight (kg) | Weight of weaning litter (kg) |
| Control group | ??18 | ??13.12±2.40 | ??72.20±9.14 A |
| Group | The nest number | Birth litter weight (kg) | Weight of weaning litter (kg) |
| Test group | ??18 | ??13.34±2.62 | ??82.21±10.45 B |
Annotate: same column shoulder motes lowercase difference person significant difference (p＜0.05), capitalization difference person difference is remarkable (p＜0.01) extremely, below each epiphase same.
By table 2 as seen, test group weaned piglet litter weight has improved 13.86% (p＜0.01) than control group.
(2) interpolation feed addictive of the present invention is as shown in table 3 to the result of piglet 35 age in days individual weights and average daily gain influence:
Table 3
| Group | The nest number | Nascent individual weight (kg) | 35 age in days individual weights (kg) | Average daily gain (kg) |
| Control group | ??18 | ??1.19±0.11 | ??7.47±0.36 A | ??0.1795±0.0100 A |
| Test group | ??18 | ??1.21±0.11 | ??8.11±0.44 B | ??0.1973±0.0120 B |
As shown in Table 3, piglet 35 age in days individual weight average specific control groups have improved 8.57% (p＜0.01); Average daily gain has improved 9.92% (p＜0.01) than control group.
(3) interpolation feed addictive of the present invention is as shown in table 4 to the result of piglet survival ratio influence:
Table 4
| Group | The nest number | Nest produces the young number (head) of living | 35 age in days nests young number (head) alive | Survival rate (%) |
| Control group | ??18 | ??197 | ??174 | ??88.32 |
| Test group | ??18 | ??198 | ??183 | ??92.42 |
As shown in Table 4, the test group piglet survival ratio has improved 4.64% than control group, and difference is remarkable (p＞0.05) not.
(4) adding feed addictive of the present invention weans as shown in table 5 to the result of influence estrus time to sow:
Table 5
| Group | Inter oestrual period (my god) |
| Control group | ??4.78±1.67 |
| Test group | ??4.67±1.08 |
As shown in Table 5, the test group sow is weaned and has shortened 0.11 day (2.30%) to estrus time than control group, and difference is remarkable (p＞0.05) not.
(5) interpolation feed addictive of the present invention is as shown in table 6 to the result of sow milk composition influence:
Table 6
| Group | Butterfat (%) | Lactoprotein (%) | Lactose (%) |
| Control group | ??8.14±0.62 | ??5.86±0.53 | ??4.81±0.52 |
| Test group | ??8.20±0.62 | ??5.97±0.56 | ??4.87±0.57 |
As shown in Table 6, the test group dairy fat content has improved 0.74% than control group; Content of milk protein has improved 1.88% than control group; Lactose content has improved 1.25% than control group, but difference all not significantly (p＞0.05).
By above-mentioned test data as can be known, behind the interpolation feed addictive of the present invention, compare with control group in the milking sow daily ration, test group weaned piglet litter weight has improved 13.86% (p＜0.01); 35 age in days individual weights have on average improved 8.57% (p＜0.01); Average daily gain has improved 9.92% (p＜0.01); Survival rate has improved 4.64% (p＞0.05); Sow is weaned and has shortened 0.11 day (2.30%) to estrus time, and the lactation amount that feed addictive of the present invention has significantly increased milking sow is added in this explanation.The test group dairy fat content has improved 0.74%; Content of milk protein has improved 1.88%; Lactose content has improved 1.25%, but difference not significantly (p＞0.05), feed addictive of the present invention is added in this explanation the trend that improves sow breast quality.In sum, adding feed addictive of the present invention improves significantly to the milk performance of milking sow.
Application examples 2
Test period: the test since on August 1st, 2006, October 21 in 2006 end of day, 82 days test periods.
Test site: the just flat plant in Xiaoshan, Hangzhou.
The selection of test pig and grouping: select 48 of the good multiparity sow accumulative totals of just before giving birth length close, conditional likelihood in term, be divided into 2 processed group, i.e. control group and test group at random according to the roughly close principle of health status, parity and the body weight of sow.Each processed group is established 3 repetitions, and each repeats 8.Brought into use in antenatal 7 days, and 41 days experimental periods, wherein 24 days lactations, observed sow and wean to the inter oestrual period first time (10 day observation period).
The test daily ration: the additive that utilizes embodiment 2 to prepare is that 0.1% zeolite powder in the basal ration prescription of 0.1% consumption substitution tables 1 is as the test daily ration according to percentage by weight.
Feeding and management: pig house carries out disinfection before the test, promptly just enters after the test pig grouping and tries the phase.The sow of control group is used basal diet feeding, the sow service test daily ration feeding of test group.Other scheme is carried out according to pig farm Routine Management program.Disease occurs and then carry out record and treatment in time.In piglet when birth, weigh by head and carry out record, and 9:00 weighs and record on an empty stomach the morning during piglet 24 ages in days (wean).Record survival number and pig mental status only etc.
Detect index: (1) performance test: is that unit record initial weight, end are heavy with the nest, and statistical average daily gain, wean (wean of 24 ages in days) litter weight, 24 age in days individual weights, record sow wean back is to interval estrus time for the first time; (2) collection and the analysis of milk sample: adopt preceding 45 minutes of breast piglet and sow isolated, in lactation the 14th day respectively in the past, in, the nipple at back three positions gathers newborn sample with adopting newborn device, merging.From sow auricular vein oxytocin injection 30 units, every sow was adopted 20mL before the breast sample was gathered, and the milk sample places-20 ℃ of freezing preservations.Adopt the content of infrared ray milk composition analysis-e/or determining butterfat, lactoprotein, lactose.
Data are handled: with application examples 1.
Test result:
(1) interpolation feed addictive of the present invention is as shown in table 7 to the result of weaned piglet litter weight influence:
Table 7
| Group | The nest number | Birth litter weight (kg) | Weight of weaning litter (kg) |
| Control group | ??24 | ??14.15±1.71 | ??61.10±10.75 a |
| Test group | ??24 | ??14.05±1.67 | ??68.57±10.42 b |
By table 7 as seen, test group weaned piglet litter weight has improved 12.23% (p＜0.05) than control group.
(2) interpolation feed addictive of the present invention is as shown in table 8 to the result of piglet 35 age in days individual weights and average daily gain influence:
Table 8
| Group | The nest number | Nascent individual weight (kg) | 24 age in days individual weights (kg) | Average daily gain (kg) |
| Control group | ??24 | ??1.42±0.08 | ??6.96±0.47 a | ??0.2306±0.0192 a |
| Test group | ??24 | ??1.39±0.11 | ??7.29±0.53 b | ??0.2457±0.0230 b |
As shown in Table 8, test group piglet 24 age in days individual weight average specific control groups have improved 4.74% (p＜0.05); Average daily gain has improved 6.55% (p＜0.05) than control group.
(3) interpolation feed addictive of the present invention is as shown in table 9 to the result of piglet survival ratio influence:
Table 9
| Group | The nest number | Nest produces the young number (head) of living | 24 age in days nests young number (head) alive | Survival rate (%) |
| Control group | ??24 | ??240 | ??211 | ??87.92 |
| Test group | ??24 | ??244 | ??226 | ??92.62 |
As shown in Table 9, behind the interpolation feed addictive of the present invention, the test group piglet survival ratio has improved 5.35% (p＞0.05) than control group in the milking sow basal diet.
(4) adding feed addictive of the present invention weans as shown in table 10 to the result of influence estrus time to sow:
Table 10
| Group | Sow wean to estrus time (my god) |
| Control group | ??4.96±1.16 |
| Test group | ??4.75±1.07 |
As shown in Table 10, add feed addictive of the present invention in the milking sow basal diet after, the test group sow is weaned and has shortened 0.21 day (4.23%) to estrus time than control group, but difference not significantly (p＞0.05).
(5) interpolation feed addictive of the present invention is as shown in table 11 to the result of sow milk composition influence:
Table 11
As shown in Table 11, behind the interpolation feed addictive of the present invention, the test group dairy fat content has improved 1.94% than control group in the milking sow basal diet; Content of milk protein has improved 3.80% than control group; Lactose content has improved 4.52% than control group, but difference not significantly (p＞0.05).
By above-mentioned test data as can be known, behind the interpolation feed addictive of the present invention, compare with control group in the milking sow daily ration, test group weaned piglet litter weight has improved 12.23% (p＜0.05); 24 age in days individual weights have on average improved 4.74% (p＜0.05); Average daily gain has improved 6.55% (p＜0.05); Survival rate has improved 5.35% (p＞0.05); Sow is weaned and has shortened 0.21 day (4.23%) to estrus time, and the lactation amount that feed addictive of the present invention has significantly increased milking sow is added in this explanation; Compare with control group, the test group dairy fat content has improved 1.94%; Content of milk protein has improved 3.80%; Lactose content has improved 4.52%, but difference not significantly (p＞0.05), feed addictive of the present invention is added in this explanation the trend that improves sow breast quality. In sum, adding feed addictive of the present invention improves significantly to the milk performance of milking sow.
Claims (6)
1. feed addictive that is used to improve lactation performance of lactating sows, it is characterized in that: described feed addictive is composed of the following components, and the total weight parts of described each component is 100 parts, wherein,
50～60 parts of the seeds of cowherb
5～8 parts of dandelions
8～10 parts of rhizoma atractylodis
5～8 parts of akebis
5 parts of the Radixs Astragali
5 parts in Radix Glycyrrhizae
All the other are zeolite powder.
2. the feed addictive that is used to improve lactation performance of lactating sows according to claim 1 is characterized in that by weight: described rhizoma atractylodis are 8 parts, and akebi is 5 parts.
3. the feed addictive that is used to improve lactation performance of lactating sows according to claim 2 is characterized in that by weight: the described seed of cowherb is 50 parts, and dandelion is 5 parts.
4. preparation method who is used to improve the feed addictive of lactation performance of lactating sows, it is characterized in that: with weight portion is that 50～60 parts the seed of cowherb, 5～8 parts dandelion, 8～10 parts rhizoma atractylodis, 5～8 parts akebi, 5 parts the Radix Astragali and 5 parts Radix Glycyrrhizae mix, after the cell grade micro mist is broken to particle diameter is 25～40 microns, add zeolite powder again and mix, the total weight parts of the described seed of cowherb, dandelion, rhizoma atractylodis, akebi, the Radix Astragali, Radix Glycyrrhizae and zeolite powder is 100 parts.
5. preparation method according to claim 4 is characterized in that: the weight portion of described rhizoma atractylodis is 8 parts, and the weight portion of akebi is 5 parts.
6. preparation method according to claim 5 is characterized in that: the weight portion of the described seed of cowherb is 50 parts, and the weight portion of dandelion is 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010200952XA CN101869224B (en) | 2010-06-11 | 2010-06-11 | Feed additive for improving lactation performance of lactating sows and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010200952XA CN101869224B (en) | 2010-06-11 | 2010-06-11 | Feed additive for improving lactation performance of lactating sows and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101869224A true CN101869224A (en) | 2010-10-27 |
| CN101869224B CN101869224B (en) | 2012-09-26 |
Family
ID=42994454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010200952XA Expired - Fee Related CN101869224B (en) | 2010-06-11 | 2010-06-11 | Feed additive for improving lactation performance of lactating sows and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101869224B (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102415512A (en) * | 2011-12-12 | 2012-04-18 | 成都巨星猪业有限公司 | Lactogenic feed additive for sows and preparation method thereof |
| CN102526175A (en) * | 2010-12-16 | 2012-07-04 | 天津中敖生物科技有限公司 | Traditional Chinese medicine composition for controlling livestock agalactia syndrome and preparation method thereof |
| CN102579597A (en) * | 2012-03-28 | 2012-07-18 | 金陵科技学院 | Chinese herbal compound prescription for preventing and curing mammitis of mammalian livestock and method for preparing same |
| CN102960550A (en) * | 2012-12-02 | 2013-03-13 | 刘太宇 | Chinese herbal galactagogue for breeding sows and preparation method |
| CN102987113A (en) * | 2012-10-08 | 2013-03-27 | 安徽长风农牧科技有限公司 | Feed additive for improving milk yield of sow |
| CN103141706A (en) * | 2013-04-02 | 2013-06-12 | 山东新希望六和集团有限公司 | Chinese herbal medicine lactagogue feed for sow and preparation method of feed |
| CN103270997A (en) * | 2013-05-10 | 2013-09-04 | 曾舟 | Management method for improving capacity of milk secretion of sow in lactation period |
| CN103564177A (en) * | 2013-10-24 | 2014-02-12 | 广西康佳龙农牧集团有限公司 | Feed for promoting lactation of sows, and preparation method of feed |
| CN105211558A (en) * | 2015-10-25 | 2016-01-06 | 梁寿禄 | A kind of method improving DHA content in milking sow milk |
| CN106387440A (en) * | 2016-10-28 | 2017-02-15 | 青岛海之源智能技术有限公司 | Blended milk for sows after delivery and preparation method thereof |
| CN106615798A (en) * | 2016-12-21 | 2017-05-10 | 广西浩昌敏再生资源利用有限公司 | Lactating sow feed capable of increasing milk yield and preparation method thereof |
| CN114432385A (en) * | 2022-02-24 | 2022-05-06 | 贵州大学 | Chinese herbal medicine formula for improving reproductive performance of sows and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1275386A (en) * | 2000-06-05 | 2000-12-06 | 塔志丽 | Pure traditional Chinese medicine fodder additives |
| CN1813853A (en) * | 2005-12-09 | 2006-08-09 | 王国平 | Chinese herbal medicine galactogogue for sow and its preparing method |
| CN101347519A (en) * | 2007-07-17 | 2009-01-21 | 王龙洲 | Chinese herbal medicine additive agent of feed for nursing sow and method of use thereof |
| CN101411401A (en) * | 2008-12-05 | 2009-04-22 | 东北农业大学 | Chinese herbal medicine additive agent for improving antioxidant ability of organism during lactation period of parent and use method thereof |
| CN101543266A (en) * | 2009-04-24 | 2009-09-30 | 邹振可 | Chinese herbal medicament additive for nursing sows and application thereof |
-
2010
- 2010-06-11 CN CN201010200952XA patent/CN101869224B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1275386A (en) * | 2000-06-05 | 2000-12-06 | 塔志丽 | Pure traditional Chinese medicine fodder additives |
| CN1813853A (en) * | 2005-12-09 | 2006-08-09 | 王国平 | Chinese herbal medicine galactogogue for sow and its preparing method |
| CN101347519A (en) * | 2007-07-17 | 2009-01-21 | 王龙洲 | Chinese herbal medicine additive agent of feed for nursing sow and method of use thereof |
| CN101411401A (en) * | 2008-12-05 | 2009-04-22 | 东北农业大学 | Chinese herbal medicine additive agent for improving antioxidant ability of organism during lactation period of parent and use method thereof |
| CN101543266A (en) * | 2009-04-24 | 2009-09-30 | 邹振可 | Chinese herbal medicament additive for nursing sows and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| 《兽医验方新编》 19910531 文传良 无乳及泌乳不足 四川科学技术出版社 351-355 1-6 , 第1版 1 * |
| 《农家参谋》 20091231 李巧云 母猪催奶十验方 22 1-6 , 第12期 2 * |
| 《湖南农业科学》 20081231 谢红兵等 中草药添加剂对哺乳母猪泌乳性能的影响 153-154，157 1-6 , 第2期 2 * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526175A (en) * | 2010-12-16 | 2012-07-04 | 天津中敖生物科技有限公司 | Traditional Chinese medicine composition for controlling livestock agalactia syndrome and preparation method thereof |
| CN102415512A (en) * | 2011-12-12 | 2012-04-18 | 成都巨星猪业有限公司 | Lactogenic feed additive for sows and preparation method thereof |
| CN102579597A (en) * | 2012-03-28 | 2012-07-18 | 金陵科技学院 | Chinese herbal compound prescription for preventing and curing mammitis of mammalian livestock and method for preparing same |
| CN102987113A (en) * | 2012-10-08 | 2013-03-27 | 安徽长风农牧科技有限公司 | Feed additive for improving milk yield of sow |
| CN102960550A (en) * | 2012-12-02 | 2013-03-13 | 刘太宇 | Chinese herbal galactagogue for breeding sows and preparation method |
| CN103141706B (en) * | 2013-04-02 | 2014-03-19 | 山东新希望六和集团有限公司 | Chinese herbal medicine lactagogue feed for sow and preparation method of feed |
| CN103141706A (en) * | 2013-04-02 | 2013-06-12 | 山东新希望六和集团有限公司 | Chinese herbal medicine lactagogue feed for sow and preparation method of feed |
| CN103270997A (en) * | 2013-05-10 | 2013-09-04 | 曾舟 | Management method for improving capacity of milk secretion of sow in lactation period |
| CN103564177A (en) * | 2013-10-24 | 2014-02-12 | 广西康佳龙农牧集团有限公司 | Feed for promoting lactation of sows, and preparation method of feed |
| CN103564177B (en) * | 2013-10-24 | 2015-02-25 | 广西康佳龙农牧集团有限公司 | Feed for promoting lactation of sows, and preparation method of feed |
| CN105211558A (en) * | 2015-10-25 | 2016-01-06 | 梁寿禄 | A kind of method improving DHA content in milking sow milk |
| CN106387440A (en) * | 2016-10-28 | 2017-02-15 | 青岛海之源智能技术有限公司 | Blended milk for sows after delivery and preparation method thereof |
| CN106615798A (en) * | 2016-12-21 | 2017-05-10 | 广西浩昌敏再生资源利用有限公司 | Lactating sow feed capable of increasing milk yield and preparation method thereof |
| CN114432385A (en) * | 2022-02-24 | 2022-05-06 | 贵州大学 | Chinese herbal medicine formula for improving reproductive performance of sows and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101869224B (en) | 2012-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869224B (en) | Feed additive for improving lactation performance of lactating sows and preparation method thereof | |
| CN102232487B (en) | Physiological regulator for maternal animals, and preparation method thereof | |
| CN102823779B (en) | Dairy cow feed, preparation method and traditional Chinese medicine for improving dairy cow production performance | |
| CN102763781A (en) | Nutrient for improving productivity of nursing sows and preparation method thereof | |
| CN106819482A (en) | Improve antibiotic-free feed of milking sow production performance and preparation method thereof | |
| CN103598426B (en) | For improving feed addictive and the feed of growth performance of chicks | |
| CN105053637A (en) | Pig intestine membrane protein-containing pigling mixed feed and preparation method thereof | |
| CN104206738A (en) | Feed additive for breeding porcupine sows and application of feed additive | |
| CN102274375A (en) | Chinese medicinal preparation for facilitating milk secretion of milking sow | |
| CN106386694A (en) | Culture method of stocking yellow cattle | |
| CN105192433A (en) | Special complete formula feed for sows in perinatal period | |
| CN105106313A (en) | Chinese herbal medicine preparation for enhancing lactation and reproduction functions of sows | |
| CN108079284A (en) | A kind of drug, its preparation method and application for improving sow production performance | |
| CN106306533A (en) | Traditional Chinese medicine feed for preventing and treating infectious bronchitis and preparation method thereof | |
| CN103931940A (en) | 4% healthcare premix of piglets | |
| CN102885201B (en) | Compound Chinese herbal medicine feed additive | |
| CN104012757B (en) | A kind of livestock and poultry nonreactive growth promotion compound traditional Chinese veterinary medicine preparation and its preparation method and application | |
| CN103316206B (en) | Chinese medicine composition for improving milk yield of sow and piglet growth performance | |
| CN105146228A (en) | Chinese herb compound preparation used for sow miscarriage prevention and preparing method thereof | |
| CN101869225B (en) | Feed additive for improving pregnancy rate of sows and preparation method thereof | |
| CN102987113A (en) | Feed additive for improving milk yield of sow | |
| CN103931941A (en) | 4% healthcare premix for service boar | |
| CN106578484A (en) | Chinese herbal medicine feed supplement for sows in suckling period | |
| CN103222565B (en) | Traditional chinese medicine milk increasing agent | |
| CN107751558A (en) | A kind of Chinese medicine preparation and preparation method of anti-milking sow heat stress increase lactation amount |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120926 Termination date: 20180611 |